81 related articles for article (PubMed ID: 2094645)
1. [Experiment study of adriamycin-induced nephrotic syndrome in rats].
Wang Z; Wang Z; Liu Z; Tan Y
Hua Xi Yi Ke Da Xue Xue Bao; 1990 Sep; 21(4):430-2. PubMed ID: 2094645
[TBL] [Abstract][Full Text] [Related]
2. Adriamycin-induced nephrotic syndrome in rats: sequence of pathologic events.
Bertani T; Poggi A; Pozzoni R; Delaini F; Sacchi G; Thoua Y; Mecca G; Remuzzi G; Donati MB
Lab Invest; 1982 Jan; 46(1):16-23. PubMed ID: 6172662
[TBL] [Abstract][Full Text] [Related]
3. Increased glomerular thromboxane synthesis as a possible cause of proteinuria in experimental nephrosis.
Remuzzi G; Imberti L; Rossini M; Morelli C; Carminati C; Cattaneo GM; Bertani T
J Clin Invest; 1985 Jan; 75(1):94-101. PubMed ID: 4038407
[TBL] [Abstract][Full Text] [Related]
4. Changes of glomerular fixed anionic charge sites in adriamycin nephrosis in rats.
Wang Z; Wang ZG; Liu Z
Chin Med J (Engl); 1991 Feb; 104(2):128-31. PubMed ID: 1714805
[TBL] [Abstract][Full Text] [Related]
5. [Changes of glomerular fixed anionic charge sites in adriamycin nephrosis in rats].
Wang Z; Wang ZG; Liu Z
Hua Xi Yi Ke Da Xue Xue Bao; 1989 Dec; 20(4):405-8. PubMed ID: 2483554
[TBL] [Abstract][Full Text] [Related]
6. Administration of pigment epithelium-derived factor (PEDF) reduces proteinuria by suppressing decreased nephrin and increased VEGF expression in the glomeruli of adriamycin-injected rats.
Fujimura T; Yamagishi S; Ueda S; Fukami K; Shibata R; Matsumoto Y; Kaida Y; Hayashida A; Koike K; Matsui T; Nakamura K; Okuda S
Nephrol Dial Transplant; 2009 May; 24(5):1397-406. PubMed ID: 19042927
[TBL] [Abstract][Full Text] [Related]
7. Steroids and Adriamycin nephrosis.
Bertani T; Remuzzi G; Rocchi G; Delaini F; Sacchi G; Falchetti M; Donati MB
Appl Pathol; 1984; 2(1):32-8. PubMed ID: 6525317
[TBL] [Abstract][Full Text] [Related]
8. Vascular dysfunction in adriamycin nephrosis: different effects of adriamycin exposure and nephrosis.
Ulu N; Buikema H; van Gilst WH; Navis G
Nephrol Dial Transplant; 2008 Jun; 23(6):1854-60. PubMed ID: 18218687
[TBL] [Abstract][Full Text] [Related]
9. Glomerular epithelial detachment, not reduced charge density, correlates with proteinuria in adriamycin and puromycin nephrosis.
Whiteside C; Prutis K; Cameron R; Thompson J
Lab Invest; 1989 Dec; 61(6):650-60. PubMed ID: 2601299
[TBL] [Abstract][Full Text] [Related]
10. IL-1-like production in adriamycin-induced nephrotic syndrome in the rat.
Bricio T; Molina A; Egido J; Gonzalez E; Mampaso F
Clin Exp Immunol; 1992 Jan; 87(1):117-21. PubMed ID: 1733626
[TBL] [Abstract][Full Text] [Related]
11. Induction of proteinuric chronic glomerular disease in the rat (Rattus norvegicus) by intracardiac injection of doxorubicin hydrochloride.
Rangan GK; Wang Y; Harris DC
Contemp Top Lab Anim Sci; 2001 Sep; 40(5):44-9. PubMed ID: 11560405
[TBL] [Abstract][Full Text] [Related]
12. Combined light and electron-microscope morphometric studies of acute puromycin aminonucleoside nephropathy in rats.
Pinto JA; Brewer DB
J Pathol; 1975 Jul; 116(3):149-64. PubMed ID: 1104792
[TBL] [Abstract][Full Text] [Related]
13. [The effect of pefloxacin on nephrotic syndrome in experimental adriamycin nephropathy].
Zima T; Tesar V; Rychlík I; Nĕmecek K; Poledne R; Stejskalová A; Tĕmínová J; Stípek S; Merta M
Cas Lek Cesk; 1995 Oct; 134(20):658-60. PubMed ID: 7489582
[TBL] [Abstract][Full Text] [Related]
14. Treatment of experimental nephrotic syndrome with artesunate.
Razavi A; Nouri HR; Mehrabian F; Mirshafiey A
Int J Toxicol; 2007; 26(4):373-80. PubMed ID: 17661229
[TBL] [Abstract][Full Text] [Related]
15. Disease Severity Correlates with Thrombotic Capacity in Experimental Nephrotic Syndrome.
Kerlin BA; Waller AP; Sharma R; Chanley MA; Nieman MT; Smoyer WE
J Am Soc Nephrol; 2015 Dec; 26(12):3009-19. PubMed ID: 25855774
[TBL] [Abstract][Full Text] [Related]
16. The influence of pefloxacine on experimental adriamycin-induced nephrotic syndrome in rats.
Zima T; Tesar V; Rychlík I; Nĕmecek K; Poledne R; Tĕmínová J; Stípek S; Merta M
Ren Fail; 1996 Mar; 18(2):195-9. PubMed ID: 8723357
[TBL] [Abstract][Full Text] [Related]
17. Evidence suggesting a role for platelet-activating factor (PAF) in experimental nephrotic syndrome.
Egido J; Mampaso F; Gómez-Chiarri M; González E; Ortíz A; Lerma JL; Robles A; Braquet P; Hernando L
Int J Tissue React; 1990; 12(4):213-20. PubMed ID: 2178155
[TBL] [Abstract][Full Text] [Related]
18. The experimental model of nephrotic syndrome induced by Doxorubicin in rodents: an update.
Pereira Wde F; Brito-Melo GE; de Almeida CA; Moreira LL; Cordeiro CW; Carvalho TG; Mateo EC; Simões E Silva AC
Inflamm Res; 2015 May; 64(5):287-301. PubMed ID: 25788426
[TBL] [Abstract][Full Text] [Related]
19. The influence of chronic ethanol administration on adriamycin-induced nephrotic syndrome in rats.
Tesar V; Zima T; Poledne R; Stejskalová A; Stípek S; Tĕmínová J
Alcohol Alcohol; 1995 Jan; 30(1):47-53. PubMed ID: 7748275
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationship for two lipoxygenase inhibitors and their potential for inducing nephrotic syndrome.
Morley TJ; Evans GO; Goodwin DA; Read NG; Hodgson ST; Hawksworth GM
Toxicol Appl Pharmacol; 1997 Oct; 146(2):299-308. PubMed ID: 9344898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
